At-home medical care for housebound ME/CFS patients
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study is testing a way to improve medical care for people with ME/CFS (including post-COVID ME/CFS) who are mostly homebound. The goal is to see if bringing healthcare to your home helps you better manage your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a formal diagnosis of ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) using the Canadian Consensus Criteria.
- You should be mostly or completely housebound—your Bell Score is 30 or below (meaning you need help with most daily activities).
- You must experience a severe flare-up of symptoms after even a little activity that lasts more than 14 hours.
- You must be between 18 and 70 years old.
- You cannot have any other condition (like a brain injury or advanced Parkinson's) that already limits your ability to move or think.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for ME/CFS (chronic fatigue syndrome) that includes symptoms like dizziness when standing. It uses a smartphone app to track your progress and aims to see if the treatment can improve your daily life.
This study tests whether breathing pure oxygen in a pressurized chamber can reduce fatigue and improve symptoms in people with mild-to-moderate chronic fatigue syndrome (ME/CFS). The therapy may help your body recover better by increasing oxygen supply to affected tissues.
This study looks at how post-exertional malaise (PEM) affects people with ME/CFS. It aims to understand the condition better and find new ways to help.
This trial tests whether a specific mind-body program can help people with Long COVID or ME/CFS feel better. It compares the program to standard care to see if it improves symptoms like fatigue and brain fog.
This study observes how a blood-cleaning treatment called immunoadsorption works in patients with ME/CFS (severe fatigue condition) who have specific immune markers. Researchers will track whether this treatment helps reduce symptoms and improve daily functioning.
This trial tests an online self-management program to help people cope with long COVID symptoms in everyday life. It may help if you’re struggling with ongoing symptoms like mood changes, memory/thinking issues, or physical problems after COVID.
Hear when a new ME/CFS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.